<span style="color: #222222;">The National Technical Advisory Group on Immunisation (NTAGI) has recommended to increase the gap between two doses of Serum Institute of India's Oxford COVID-19 vaccine, Covishield, to 12 to 16 weeks. Currently, the interval between two doses of Covishield is four to eight weeks. The panel has, however, kept the dosage interval for Covaxin unchanged.<br />''<br />''NTAGI has also recommended that those who have tested positive for COVID-19 and are waiting to take the vaccine should defer vaccination for six months after recovery.   It said that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women can be inoculated any time after delivery. The recommendations of the NTAGI will be sent to the National Expert Group on Vaccine Administration for COVID-19.</span><br />